Clene Inc

NASDAQ:CLNN

3.90

-0.05 (-1.27%)

4:58:11 PM EDT: $3.90 0.00 (0.00%)

Market Cap (Intraday)	34.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.07 Million
Adjusted EPS	-$0.47

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121

United States of America

Phone: +1.801.676.9695

Number of Employees: 85

http://www.clene.com

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.